PEPDar: A randomized prospective noninferiority study of ritonavir-boosted darunavir for HIV post-exposure prophylaxis-Reference-Cited by-同舟云学术

PEPDar: A randomized prospective noninferiority study of ritonavir-boosted darunavir for HIV post-exposure prophylaxis

Published:2016-05-11 Issue:6 Volume:17 Page:453-459
ISSN:1464-2662
Container-title:HIV Medicine
language:en
Short-container-title:HIV Med

Author:

Fätkenheuer G¹²,Jessen H³,Stoehr A⁴,Jung N¹,Jessen AB³,Kümmerle T¹,Berger M⁵,Bogner JR⁶,Spinner CD⁷,Stephan C⁸,Degen O⁹,Vogelmann R¹⁰,Spornraft-Ragaller P¹¹,Schnaitmann E¹²,Jensen B¹³,Ulmer A¹⁴,Kittner JM¹⁵,Härter G¹⁶,Malfertheiner P¹⁷,Rockstroh J¹⁸,Knecht G¹⁹,Scholten S²⁰,Harrer T²¹,Kern WV²²,Salzberger B²³,Schürmann D²⁴,Ranneberg B²⁵

Affiliation:

1. Department I of Internal Medicine; University Hospital of Cologne; Cologne Germany

2. German Centre for Infection Research, partner site Bonn-Cologne; Cologne Germany

3. Praxis Jessen2 + Kollegen; Berlin Germany

4. ifi - Institute for Interdisciplinary Medicine; Study Centre St. Georg; Hamburg Germany

5. Immunology Outpatient Clinic; Vivantes Auguste Viktoria Hospital; Berlin Germany

6. Section Infectcious Diseases, Med IV; University Hospital of Munich; Munich Germany

7. Department of Medicine II; University Hospital Klinikum rechts der Isar; Munich Germany

8. Department of Medicine; Center for Internal Medicine; J. W. Goethe-University Frankfurt; Frankfurt am Main Germany

9. Outpatient Infectious Diseases Unit; University Center Hamburg Eppendorf; Hamburg Germany

10. Department of Internal Medicine; Medical Clinic II; Ruprecht-Karls-University Heidelberg; Mannheim Germany

11. University Hospital Karl Gustav Carus; Dresden Germany

12. Infectomed; Stuttgart Germany

13. Department of Gastroenterology, Hepatology and Infectiology; University Hospital Düsseldorf; Düsseldorf Germany

14. Group Practice Ulmer/Frietsch/Müller/Roll; Stuttgart Germany

15. Medical Clinic and Outpatient Clinic I; University Hospital Mainz; Mainz Germany

16. Clinic for Internal Medizin III; Ulm University Medical Center; Ulm Germany

17. Clinic for Gastroenterology, Hepatology and Infectiology; University Hospital Magdeburg; Magdeburg Germany

18. Internal Medicine I, Gastroenterology, Infectious Diseases; University Hospital Bonn; Bonn Germany

19. Internal Medicine Specialist Center Stresemannallee; Frankfurt am Main Germany

20. Practice Hohenstaufenring; Cologne Germany

21. Department of Medicine 3; University Medicine Erlangen; Erlangen Germany

22. Division of Infectious Diseases; University Hospital; Freiburg Germany

23. Department Internal Medicine I; University Regensburg; Regensburg Germany

24. Division of Infectiology and Pneumonology; Medical Department; Charité-University Medicine Berlin; Berlin Germany

25. Janssen-Cilag; Neuss Germany

Funder

Janssen-Cilag GmbH, Germany

Bundesministerium für Bildung und Forschung

Deutsches Zentrum für Infektionsforschung

Publisher

Wiley

Subject

Pharmacology (medical),Infectious Diseases,Health Policy

Reference27 articles.

1. Antiretroviral post-exposure prophylaxis (PEP) for occupational HIV exposure;Young;Cochrane Database Syst Rev,2007

2. Practical guidance for nonoccupational postexposure prophylaxis to prevent HIV infection: an editorial review;Jain;AIDS,2014

3. A case-control study of HIV seroconversion in health care workers after percutaneous exposure;Cardo;N Engl J Med,1997

4. Public Health Service guidelines for the management of health-care worker exposures to HIV and recommendations for postexposure prophylaxis;Centers for Disease Control and Prevention;MMWR Recomm Rep,1998

5. Seroconversion to HIV-1 following a needlestick injury despite combination post-exposure prophylaxis;Hawkins;J Infect,2001

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Post-exposure prophylaxis to prevent HIV: new drugs, new approaches, and more questions;The Lancet HIV;2023-12

2. UK guideline for the use of HIV post‐exposure prophylaxis 2021;HIV Medicine;2022-02-14

3. Post-exposure prophylaxis against SARS-CoV-2 in close contacts of confirmed COVID-19 cases (CORIPREV): study protocol for a cluster-randomized trial;Trials;2021-03-22

4. Network meta‐analysis of post‐exposure prophylaxis randomized clinical trials;HIV Medicine;2020-10-27

5. HIV transmission by human bite: a case report and review of the literature—implications for post-exposure prophylaxis;Infection;2020-07-26